Acute and Sub-acute toxicity studies for FDA ANDAs [Regulatives / Guidelines]

posted by Achievwin – US, 2024-08-27 04:42 (257 d 01:00 ago) – Posting: # 24162
Views: 1,307

❝ The guideline says "For all injectable, the sub-acute toxicity should be submitted on the Test product of the sponsor, studied in at least two species for minimum 14 days".


❝ This is not the new requirement.


Most un scientific requirement.... neither FDA nor EMA ask this for generic products.

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,668 registered users;
133 visitors (0 registered, 133 guests [including 7 identified bots]).
Forum time: 05:43 CEST (Europe/Vienna)

Lack of clarity is always a sign of dishonesty.    Celia Green

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5